These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2818993)

  • 1. Effect on the 24-hour diurnal curve of intraocular pressure of a fixed ratio combination of timolol 0.5% and pilocarpine 2% in patients with COAG not controlled on timolol 0.5%.
    Maclure GM; Vogel R; Sturm A; Binkowitz B
    Br J Ophthalmol; 1989 Oct; 73(10):827-31. PubMed ID: 2818993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical experience with a fixed dose combination therapy of timolol and pilocarpine used twice daily in the management of chronic open angle glaucoma.
    Moriarty AP; Dowd TC; Trimble RB
    Eye (Lond); 1994; 8 ( Pt 4)():410-3. PubMed ID: 7821462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular pressure-lowering effects of latanoprost monotherapy versus latanoprost or pilocarpine in combination with timolol: a randomized, observer-masked multicenter study in patients with open-angle glaucoma. Italian Latanoprost Study Group.
    Bucci MG
    J Glaucoma; 1999 Feb; 8(1):24-30. PubMed ID: 10084271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-masked study of timolol and pilocarpine combined.
    Airaksinen PJ; Valkonen R; Stenborg T; Takki K; Klemetti A; Kontkanen M; Oskala P
    Am J Ophthalmol; 1987 Dec; 104(6):587-90. PubMed ID: 3318475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension.
    Kałuzny J; Sobecki R; Czechowicz-Janicka K; Kecik D; Kałuzny BJ; Stewart JA; Stewart WC
    Acta Ophthalmol; 2008 Dec; 86(8):860-5. PubMed ID: 18721251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timolol-pilocarpine fixed-ratio combinations in the treatment of chronic open angle glaucoma. A controlled multicenter study of 48 weeks. Scandinavian Timpilo Study Group.
    Puustjärvi TJ; Repo LP
    Arch Ophthalmol; 1992 Dec; 110(12):1725-9. PubMed ID: 1342582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of changing from concomitant timolol pilocarpine to bimatoprost monotherapy on ocular blood flow and IOP in primary chronic angle closure glaucoma.
    Agarwal HC; Gupta V; Sihota R
    J Ocul Pharmacol Ther; 2003 Apr; 19(2):105-12. PubMed ID: 12804055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Timolol 0.5%/dorzolamide 2% fixed combination versus timolol 0.5%/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients].
    Kałuzny JJ; Szaflik J; Czechowicz-Janicka K; Kałuzny J; Orzałkiewicz A; Zaleska-Zmijewska A; Krajewska M; Stewart JA; Leech JN; Stewart WC
    Klin Oczna; 2004; 106(1-2 Suppl):241-2. PubMed ID: 15510513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the intraocular pressure lowering effect of latanoprost and a fixed combination of timolol-pilocarpine eye drops in patients insufficiently controlled with beta adrenergic antagonists. French Latanoprost Study Group, and the Swedish Latanoprost Study Group.
    Nordmann JP; Söderström M; Rouland JF; Malecaze F
    Br J Ophthalmol; 2000 Feb; 84(2):181-5. PubMed ID: 10655195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timolol-pilocarpine combined vs timolol and pilocarpine given separately.
    Söderström MB; Wallin O; Granström PA; Thorburn W
    Am J Ophthalmol; 1989 May; 107(5):465-70. PubMed ID: 2653044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of dorzolamide/timolol and latanoprost/timolol fixed combinations on diurnal intraocular pressure control in primary open-angle glaucoma.
    Eren MH; Gungel H; Altan C; Pasaoglu IB; Sabanci S
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):381-6. PubMed ID: 22320418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effect of apraclonidine on intraocular pressure in glaucoma patients receiving timolol and pilocarpine.
    Yüksel N; Elibol O; Caglar Y; Alçelik T
    Ophthalmologica; 1997; 211(6):354-7. PubMed ID: 9380353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, long-term, randomized study of the efficacy and safety of the drug combination pilocarpine 1% with clonidine 0.06% or clonidine 0.125% versus timolol 0.25%.
    Sihota R; Rajashekhar YL; Venkatesh P; Agarwal H
    J Ocul Pharmacol Ther; 2002 Dec; 18(6):499-506. PubMed ID: 12537676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using diurnal intraocular pressure fluctuation to assess the efficacy of fixed-combination latanoprost/timolol versus latanoprost or timolol monotherapy.
    Varma R; Hwang LJ; Grunden JW; Bean GW
    Br J Ophthalmol; 2010 Jan; 94(1):80-4. PubMed ID: 19692375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M; Reis A; Sano ME; Susanna R
    J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between pilocarpine and timolol on diurnal pressures in open-angle glaucoma.
    Hass I; Drance SM
    Arch Ophthalmol; 1980 Mar; 98(3):480-1. PubMed ID: 7189114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four-hour diurnal curve comparison of commercially available latanoprost 0.005% versus the timolol and dorzolamide fixed combination.
    Konstas AG; Papapanos P; Tersis I; Houliara D; Stewart WC
    Ophthalmology; 2003 Jul; 110(7):1357-60. PubMed ID: 12867391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circadian intraocular pressure control with dorzolamide versus timolol maleate add-on treatments in primary open-angle glaucoma patients using latanoprost.
    Tamer C; Oksüz H
    Ophthalmic Res; 2007; 39(1):24-31. PubMed ID: 17164574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined timolol and pilocarpine vs pilocarpine alone and timolol alone in the treatment of glaucoma.
    Zadok D; Geyer O; Zadok J; Lazar M; Krakowski D; Nemet P
    Am J Ophthalmol; 1994 Jun; 117(6):728-31. PubMed ID: 8198156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.